DeepMed Research

BIOSENSE WEBSTER, INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1970-01-01

Employees: 1K

Market Cap: -

Website: http://www.biosensewebster.com

Clinical Trials

LINEAR II - LME-159 Evaluation of a Multi-Electrode Linear Type Ablation Catheter

Phase 1

Completed

Conditions: Cavotricuspid Isthmus Dependent Right Atrial Flutter

Interventions: Procedure: Endocardial Ablation

First Posted Date: 2014-10-06

Last Posted Date: 2025-02-03

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 12

Registration Number: NCT02257060

Locations: 🇮🇹
Miulli Hospital, Acquaviva Delle Fonti, Bari/Strada, Italy

Picasso NAV High-Density Mapping Catheter for Signal Analysis of Complex Arrhythmias - First-In-Man

Phase 1

Completed

Conditions: Arrhythmias

Interventions: Procedure: Ablation procedure
Device: Picasso NAV Catheter

First Posted Date: 2014-04-10

Last Posted Date: 2025-02-03

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 30

Registration Number: NCT02110004

Locations: 🇨🇿
Na Homolce Hospital, Prague, Czech Republic
🇧🇪
OLV Hospital, Aalst, Belgium

RENABLATE-II Feasibility Study of Catheter Based Renal Denervation to Treat Resistant Hypertension - 157

Phase 1

Completed

Conditions: Hypertension, Renal

Interventions: Device: Celsius® ThermoCool® Renal Denervation

First Posted Date: 2014-03-26

Last Posted Date: 2025-02-04

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 19

Registration Number: NCT02095691

Locations: 🇨🇿
Charles University Hospital, Prague, Czech Republic
🇨🇿
Na Homolce Hospital, Prague, Czech Republic
🇪🇸
Hospital Universitari Clinic de Barcelona, Barcelona, Spain

and more 2 locations

Oral Anticoagulation Therapy Pilot Study

Phase 4

Terminated

Conditions: Paroxysmal Atrial Fibrillation

Interventions: Other: On OAT Group (Control)
Other: Off OAT Group (Test)

First Posted Date: 2013-10-10

Last Posted Date: 2025-02-04

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 80

Registration Number: NCT01959425

Locations: 🇺🇸
MetroHealth Medical Center, Cleveland, Ohio, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
University of Kansas Hospitals, Kansas City, Kansas, United States

and more 4 locations

nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

Phase 3

Terminated

Conditions: Atrial Fibrillation

Interventions: Device: NaviStar ThermoCool Catheters
Device: nMARQ Navigation Catheters

First Posted Date: 2013-04-04

Last Posted Date: 2025-02-04

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 481

Registration Number: NCT01824394

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Valley Hospital, Ridgewood, New Jersey, United States
🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

and more 45 locations

RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension

Phase 1

Completed

Conditions: Hypertension, Renal

Interventions: Device: Celsius® ThermoCool® RD

First Posted Date: 2012-12-25

Last Posted Date: 2025-02-04

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 35

Registration Number: NCT01756300

Locations: 🇨🇿
Na Homolce Hospital, Prague, Czech Republic
🇦🇺
Peninsula Heart Centre, Frankston, Victoria, Australia
🇧🇪
Onze-Lieve-Vrouwziekenhuis Aalst, Aalst, Belgium

and more 4 locations

CARTO® 3 System and Real Time Intracardiac Ultrasound

Completed

Conditions: Atrial Fibrillation
Paroxysmal AF

Interventions: Device: Catheter Ablation

First Posted Date: 2012-10-30

Last Posted Date: 2014-12-01

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 234

Registration Number: NCT01716663

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Scott & White Memorial Hospital, Temple, Texas, United States
🇺🇸
Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, United States

and more 23 locations

THERMOCOOL® SMARTTOUCH™ Registry

Completed

Conditions: Symptomatic Atrial Fibrillation

First Posted Date: 2012-08-31

Last Posted Date: 2025-02-03

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 426

Registration Number: NCT01677052

Locations: 🇬🇧
Royal Bournemouth Hospital, Bournemouth, United Kingdom
🇬🇧
Glenfield Hospital, Leicester, Leicester, United Kingdom
🇨🇦
University of Ottawa Heart Institute, Ottawa, Ontario, Canada

and more 26 locations

THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS

Phase 3

Completed

Conditions: Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation

Interventions: Device: THERMOCOOL® SMARTTOUCH™ Catheter

First Posted Date: 2012-07-12

Last Posted Date: 2018-05-15

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 148

Registration Number: NCT01639495

Locations: 🇺🇸
Loyola University Chicago, Maywood, Illinois, United States
🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸
Abbott Northwestern Hospital, Minneapolis, Minnesota, United States

and more 17 locations

NAVISTAR® THERMOCOOL® SF Catheter: Observational Study

Completed

Conditions: Atrial Fibrillation
Paroxysmal Arrhythmia

Interventions: Device: Catheter Ablation (NAVISTAR® THERMOCOOL® SF Catheter)

First Posted Date: 2012-04-26

Last Posted Date: 2015-01-26

Lead Sponsor: Biosense Webster, Inc.

Target Recruit Count: 511

Registration Number: NCT01585961

Locations: 🇺🇸
Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, Texas, United States
🇺🇸
Arizona Heart Hospital, Phoenix, Arizona, United States
🇺🇸
Alaska Heart Institute, LLC, Anchorage, Alaska, United States

and more 42 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy